Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Many prostate cancer patients receive wrong treatment

Prostate cancer patients often receive treatment that is contraindicated by pre-existing conditions, like urinary or bowel dysfunction, according to a new study.

26 Nov 2007

Doctors may be missing cancers in obese men due to misleading PSA scores

Doctors may be missing cancers in obese men because the telltale blood marker used to detect the disease can be falsely interpreted as low in this population, according to a new study led by Duke Prostate Center researchers.

21 Nov 2007

The science of cancer health disparities in racial/ethnic minorities and the medically underserved

The latest biological, clinical and social research behind how cancer affects different racial and ethnic groups will be the focus of the first American Association for Cancer Research conference on the topic, entitled "The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved."

21 Nov 2007

PSA test in obese men can produce false results

Scientists in the United States suggest a blood test widely used to screen for prostate cancer can be misleading in the case of men who are obese.

20 Nov 2007

Cannabis compound may stop the spread of breast cancer cells

A compound found in cannabis may prove to be effective at helping stop the spread of breast cancer cells throughout the body.

19 Nov 2007

Should the UK lower the age for prostate cancer detection in line with the USA?

19 Nov 2007

Diet low in carbohydrates may stunt prostate tumor growth

A diet low in carbohydrates may help stunt the growth of prostate tumors, according to a new study led by Duke Prostate Center researchers. The study, in mice, suggests that a reduction in insulin production possibly caused by fewer carbohydrates may stall tumor growth.

14 Nov 2007

Obesity is an independant risk factor for prostate cancer-related death

Men who are overweight or obese when diagnosed with prostate cancer are at greater risk of death after treatment, according to a new study in the December 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

13 Nov 2007

Caregivers benefit from cancer support programs

As cancer care begins to address the emotional needs of patients, a new study from researchers at the University of Michigan Comprehensive Cancer Center shows that it's important to address the caregiver's emotional needs as well.

13 Nov 2007

Early diagnosis of prostate cancer

Treating prostate cancer is a race against time. By the time the patient can feel the first symptoms, the disease has usually spread too far.

6 Nov 2007

Bavarian Nordic updates on vaccine project pipeline

In a business update, Danish-based biopharmaceutical company Bavarian Nordic, reported a number of developments in its vaccine project pipeline.

6 Nov 2007

British experts promise to double lung cancer survival rates

Lung cancer is one of the developed world's biggest cancer killers; it causes 33,000 deaths each year in Britain, claims the lives of 7,000 Australians each year and in 2007 it is estimated that 160,390 Americans will die from the disease.

6 Nov 2007

SENP1 protein may provide a basis for future targeted cancer therapies

Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.

2 Nov 2007

Supplements do not reduce cancer risk

Most experts agree that supplements add little, if anything, to a well-balanced diet.

2 Nov 2007

Discovery of gene variant linked to prostate cancer in African Americans

Researchers report a newly identified genetic variation that is linked to higher incidence of prostate cancer in African American men.

1 Nov 2007

Radiation seed implant decreases risk of death over watchful waiting/active surveillance for prostate cancer

Prostate cancer patients cut their risk of dying of the disease in half when they receive radiation seed implants (brachytherapy) to treat their cancer, compared to those who don't receive active treatment (watchful waiting/active surveillance), within six months from being diagnosed with localized prostate cancer, according to a study presented October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

1 Nov 2007

New genetic variant associated with prostate cancer in African-Americans

Two tiny genetic variations may provide the best clues yet for finding more precise ways to estimate prostate cancer risk and improve screening and early detection for men of African descent, report researchers from the University of Chicago and the Translational Genomics Research Institute, Phoenix, AZ, in the December 2007 issue of Genome Research, published early online.

1 Nov 2007